Ultra-fine needle, virtually painless
Mounjaro — 15-25% weight loss
Tirzepatide is a new-generation weight loss medication with dual GIP/GLP-1 action, approved by the US FDA and European EMA. Prescribed and monitored directly by a specialist doctor.
Transparent pricing
Includes: doctor consultation, medication, injection guidance, nutrition advice.
Start with 2.5mg. Your doctor will gradually adjust the dose. Dose changes within 3/6-month packages are fine.
📦 Delivery details
- Refrigerated (cool) Yamato courier — next-day within Tokyo, 1–2 days elsewhere in Japan
- Time slots: morning / 14–16 / 16–18 / 18–20 / 19–21
- Most homes, apartments, and hotels can receive refrigerated packages
- Not sure? Our team confirms your setup during the consultation
- Prefer pickup? Find your nearest Yamato office →
- Cool-chain shipping (Yamato) charged separately at cost
4 simple steps
Book online consultation
Video call with a specialist doctor. English support throughout the entire process.
Receive medication at your hotel
Mounjaro delivered to your Tokyo hotel within 24 hours. Cold-chain stored to medical standards.
Self-inject once a week
Ateos auto-pen — just press the button. English instructions included.
Take it home, doctor follows up
Up to 6-month prescription. Online check-ins from your home country — no need to fly back to Japan.
Specialist doctor
Direct consultation with our clinic director — a nephrology specialist and Harvard graduate.
Dr. Hoichi Amano
Director, eHealth Clinic Shinjuku
Nephrology & Anti-aging specialist
eHealth Clinic Shinjuku
1-minute walk from Shinjuku-sanchome station. Open Saturdays, Sundays & public holidays.
Same clinic. Home delivery or in-person consultation.
English-speaking residents of Japan can access the same Mounjaro program in two ways: fully online with home delivery via Yamato cool courier, or in-person at our Shinjuku clinic (1-minute walk from Shinjuku-sanchome station). Same Harvard-trained physician, same transparent pricing.
Learn before you book
In-depth guides for international patients considering medical weight loss in Japan:
Important notice: Mounjaro (Tirzepatide) is approved by the US FDA and European EMA for the treatment of obesity. In Japan, the drug is approved for type 2 diabetes treatment. Prescription for weight loss purposes is provided as private (self-paid) medical care.
Possible side effects include: nausea, diarrhea, constipation. In rare cases: pancreatitis, gallstones. Your doctor will monitor and respond promptly.
Medication is supplied through authorized pharmaceutical distributors in Japan.